SpringWorks Therapeutics Inc (SWTX)
35.63
+0.85
(+2.44%)
USD |
NASDAQ |
Dec 20, 16:00
35.66
+0.03
(+0.08%)
After-Hours: 20:00
SpringWorks Therapeutics Profit Margin (Quarterly): -108.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| PTC Therapeutics Inc | -54.20% |
| Blueprint Medicines Corp | -43.90% |
| Edgewise Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.38% |
| Return on Assets | -44.72% |
| Return on Invested Capital | -51.38% |
| Gross Profit Margin (Quarterly) | 93.22% |
| Operating Margin (Quarterly) | -117.5% |
| Return on Net Operating Assets | -569.7% |